Moleculin Biotech, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
MBRX chart
What traders are saying about $MBRX
Latest postsMoleculin Biotech, Inc. news
- Moleculin Biotech (MBRX) Reports Promising Preclinical Data on A
GuruFocus ·
- Form 8K Moleculin Biotech Inc For: 10 November By Investing.com
Investing.com India ·
- Moleculin Biotech (MBRX): Preclinical data: Annamycin plus PD-1...
Quantisnow ·
- Preclinical Data Show Annamycin Makes Pancreatic Cancer Responsive to Checkpoint Inhibitors, Opening a Combination Path with Immunotherapies
Yahoo Finance ·
- Pancreatic cancer is hard to treat with immune drugs. A drug combo extended survival in mice.
Stock Titan ·
- Moleculin Biotech, Inc. News — LSE:0K2H
TradingView ·
- Moleculin Biotech Inc expected to post a loss of $8.87 a share - Earnings Preview
TradingView ·
- Moleculin Biotech, Inc. (0K2H.L) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Moleculin Biotech, Inc. (0K2H.L) Seasonal returns chart
Yahoo Finance UK ·
- Net income of Moleculin Biotech, Inc. – LS:A42P30
TradingView ·
- Moleculin Biotech (MBRX) Stock Price, Chart & Analysis
debelegger.nl ·
- Moleculin Biotech, Inc. (MBRX) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
Moleculin Biotech, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | $33.6M | $26.0M | $29.8M | -$29.0M |
| Total assets (year end) | $22.1M | $16.9M | $38.2M | $57.4M |
| Cash and equivalents (year end) | $8.9M | $4.3M | $23.6M | $43.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Moleculin Biotech, Inc.
- Ticker
- MBRX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1659617
Frequently asked questions
What exchange is Moleculin Biotech, Inc. listed on?
Moleculin Biotech, Inc. trades on the Nasdaq under the ticker symbol MBRX.
What industry is Moleculin Biotech, Inc. in?
Moleculin Biotech, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Moleculin Biotech, Inc. headquartered?
Moleculin Biotech, Inc.'s business address on file with the SEC is in Houston, TX.
When does Moleculin Biotech, Inc.'s fiscal year end?
Moleculin Biotech, Inc.'s fiscal year ends on December 31.
How much revenue did Moleculin Biotech, Inc. report?
Moleculin Biotech, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.